ERAP1 and ankylosing spondylitis

Current Opinion in Immunology

Volumn 25, Issue 1, 2013, Pages 97-102

  Keidel, Sarah ^a,b   Chen, Liye ^c   Pointon, Jennifer ^a,b   Wordsworth, Paul ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ARGININE; ASPARAGINE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2; GLUTAMIC ACID; GLUTAMINE; HLA B27 ANTIGEN; INTERLEUKIN 23 RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSINE; SERINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; CHROMOSOME 5; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; ENTERITIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INNATE IMMUNITY; MOLECULAR PATHOLOGY; MULTIFACTORIAL INHERITANCE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSORIASIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UNFOLDED PROTEIN RESPONSE;

AMINOPEPTIDASES; ANIMALS; ANTIGEN PRESENTATION; DRUG DISCOVERY; ENDOPLASMIC RETICULUM; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MOLECULAR TARGETED THERAPY; POLYMORPHISM, GENETIC; PSORIASIS; SPONDYLITIS, ANKYLOSING;

EID: 84875255104     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.11.002     Document Type: Review

References (44)

1. Kochan G., Krojer T., Harvey D., Fischer R., Chen L., Vollmar M., von Delft F., Kavanagh K.L., Brown M.A., Bowness P., et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 2011, 108:7745-7750.
2. Thomas G.P., Brown M.A. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010, 233:162-180.
3. Brown M.A., Pile K.D., Kennedy L.G., Calin A., Darke C., Bell J., Wordsworth B.P., Cornelis F. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996, 55:268-270.
4. Gabriel S.E., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009, 11:229.
5. D'Amato M., Fiorillo M.T., Galeazzi M., Martinetti M., Amoroso A., Sorrentino R. Frequency of the new HLA-B*2709 allele in ankylosing spondylitis patients and healthy individuals. Dis Markers 1995, 12:215-217.
6. Paladini F., Taccari E., Fiorillo M.T., Cauli A., Passiu G., Mathieu A., Punzi L., Lapadula G., Scarpa R., Sorrentino R. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005, 52:3319-3321.
7. Hammer R.E., Maika S.D., Richardson J.A., Tang J.P., Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
8. Taurog J.D., Dorris M.L., Satumtira N., Tran T.M., Sharma R., Dressel R., van den Brandt J., Reichardt H.M. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009, 60:1977-1984.
9. Smith J.A., Marker-Hermann E., Colbert R.A. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol 2006, 20:571-591.
10. McHugh K., Bowness P. The link between HLA-B27 and SpA - new ideas on an old problem. Rheumatology (Oxford) 2012, 51:1529-1539.
11. Brown M.A., Kennedy L.G., MacGregor A.J., Darke C., Duncan E., Shatford J.L., Taylor A., Calin A., Wordsworth P. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997, 40:1823-1828.
12. Brown M.A. Progress in the genetics of ankylosing spondylitis. Brief Funct Genomics 2011, 10:249-257.
13. Khan M.A. Epidemiology of HLA-B27 and arthritis. Clin Rheumatol 1996, 15(Suppl. 1):10-12.
14. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337.
15. Harvey D., Pointon J.J., Evans D.M., Karaderi T., Farrar C., Appleton L.H., Sturrock R.D., Stone M.A., Oppermann U., Brown M.A., et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009, 18:4204-4212.
16. Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., Jin R., Zhou X., Bradbury L.A., Appleton L.H., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010, 42:123-127.
17. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., Oppermann U., Dilthey A., Pirinen M., Stone M.A., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011, 43:761-767.
18. Trynka G., Hunt K.A., Bockett N.A., Romanos J., Mistry V., Szperl A., Bakker S.F., Bardella M.T., Bhaw-Rosun L., Castillejo G., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011, 43:1193-1201.
19. Davidson S.I., Wu X., Liu Y., Wei M., Danoy P.A., Thomas G., Cai Q., Sun L., Duncan E., Wang N., et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009, 60:3263-3268.
20. Choi C.B., Kim T.H., Jun J.B., Lee H.S., Shim S.C., Lee B., Pope A., Uddin M., Rahman P., Inman R.D. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann Rheum Dis 2009, 69:582-584.
21. Pimentel-Santos F.M., Ligeiro D., Matos M., Mourao A.F., Sousa E., Pinto P., Ribeiro A., Sousa M., Barcelos A., Godinho F., et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 2009, 27:800-806.
22. Lin Z., Bei J.X., Shen M., Li Q., Liao Z., Zhang Y., Lv Q., Wei Q., Low H.Q., Guo Y.M., et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet 2012, 44:73-77.
23. Wang C.M., Ho H.H., Chang S.W., Wu Y.J., Lin J.C., Chang P.Y., Wu J., Chen J.Y. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther 2012, 14:R125.
24. Maksymowych W.P., Inman R.D., Gladman D.D., Reeve J.P., Pope A., Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009, 60:1317-1323.
25. Brown M.A., Brophy S., Bradbury L., Hamersma J., Timms A., Laval S., Cardon L., Calin A., Wordsworth B.P. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 2003, 48:2234-2239.
26. Haroon N., Maksymowych W.P., Rahman P., Tsui F.W., O'Shea F.D., Inman R.D. Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort. Arthritis Rheum 2012, 64:1119-1126.
27. Tsui F.W., Haroon N., Reveille J.D., Rahman P., Chiu B., Tsui H.W., Inman R.D. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2010, 69:733-736.
28. Harvey D., Pointon J.J., Karaderi T., Appleton L.H., Farrar C., Wordsworth B.P. A common functional variant of endoplasmic reticulum aminopeptidase 2 (ERAP2) that reduces major histocompatibility complex class I expression is not associated with ankylosing spondylitis. Rheumatology (Oxford) 2011, 50:1720-1721.
29. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42:985-990.
30. Guerini F.R., Cagliani R., Forni D., Agliardi C., Caputo D., Cassinotti A., Galimberti D., Fenoglio C., Biasin M., Asselta R., et al. A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS ONE 2012, 7:e29931.
31. Bremander A., Petersson I.F., Bergman S., Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011, 63:550-556.
32. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., Lees C.W., Balschun T., Lee J., Roberts R., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
33. Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
34. Evnouchidou I., Kamal R.P., Seregin S.S., Goto Y., Tsujimoto M., Hattori A., Voulgari P.V., Drosos A.A., Amalfitano A., York I.A., et al. Cutting Edge: coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 2011, 186:1909-1913.
35. Goto Y., Hattori A., Ishii Y., Tsujimoto M. Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 2006, 580:1833-1838.
36. Cifaldi L., Romania P., Lorenzi S., Locatelli F., Fruci D. Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci 2012, 13:8338-8352.
37. Cui Xea Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002, 110:515-526.
38. Gorman J.D., Sack K.E., Davis J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002, 346:1349-1356.
39. Hammer G.E., Gonzalez F., Champsaur M., Cado D., Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006, 7:103-112.
40. Saveanu L., Carroll O., Lindo V., Del Val M., Lopez D., Lepelletier Y., Greer F., Schomburg L., Fruci D., Niedermann G., et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 2005, 6:689-697.
41. Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., Zikos C., Rock K.L., Goldberg A.L., Stratikos E., Stern L.J. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 2011, 18:604-613.
42. Haroon N., Tsui F.W., Uchanska-Ziegler B., Ziegler A., Inman R.D. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis 2012, 71:589-595.
43. Colbert R.A., DeLay M.L., Klenk E.I., Layh-Schmitt G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev 2010, 233:181-202.
44. Bowness P. HLA B27 in health and disease: a double-edged sword?. Rheumatology (Oxford) 2002, 41:857-868.